Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:13 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
NCT02498444 · Stanford University · NA · terminated · last registry update 2022-03-31 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Interim futility analysis” | – | Registry record, Stanford University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGIR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-02-10Results posted on the registry: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, Sotatercept (NCT03738150)
- 2023-02-01Also stopped (terminated): Jewish General Hospital, Lidocaine + Placebo (NCT01433328)
- 2022-12-14Phase 3 first posted: Insmed Incorporated, Treprostinil Palmitil + Placebo (NCT05649748)
- 2022-12-14Phase 3 first posted: Insmed Incorporated, Treprostinil Palmitil Inhalation Powder + Placebo (NCT05649722)
- 2022-12-02Results posted on the registry: United Therapeutics, Inhaled Treprostinil (NCT02633293)
- 2022-12-02Also stopped (terminated): United Therapeutics, Inhaled Treprostinil (NCT02633293)
- 2022-09-19Results posted on the registry: Actelion, ACT-293987 (NCT01112306)
- 2022-06-02Results posted on the registry: United Therapeutics, UT-15C (treprostinil diolamine) (NCT01560637)
- 2022-04-12Results posted on the registry: Inova Health Care Services, Inhaled Treprostinil (NCT02178566)
- 2022-04-12Also stopped (terminated): Inova Health Care Services, Inhaled Treprostinil (NCT02178566)
- 2022-02-25Phase 3 first posted: United Therapeutics, Placebo + Inhaled Treprostinil (NCT05255991)
- 2022-01-05Phase 3 first posted: Actelion, Macitentan + Selexipag (NCT05179876)
- 2021-12-22Results posted on the registry: United Therapeutics, Ralinepag (NCT02279745)
- 2021-09-13Also stopped (terminated): Liquidia Technologies, Inc., Inhaled dry powder treprostinil (LIQ861) (NCT03884465)
- 2021-07-13Results posted on the registry: United Therapeutics, Inhaled Treprostinil + Placebo (NCT02630316)
- 2021-06-10Results posted on the registry: Stanford University, Oral treprostinil (NCT02663895)
- 2021-05-28Phase 3 first posted: United Therapeutics, Inhaled Treprostinil (NCT04905693)
- 2021-05-10Results posted on the registry: United Therapeutics, Oral Treprostinil (NCT01027949)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision